| Sartorius. | 238,70 € | +1,57% | ||
| Sartorius. | 190,00 € | +1,39% | ||
| Qiagen NV | 31,61 € | +0,65% | ||
| BB Biote. | 41,70 ¤ | 0,00% | ||
| Evotec SE | 4,892 € | -0,69% | ||
| Formyco. | 19,88 € | -0,85% | ||
| Heidelbe. | 2,57 € | -1,15% | ||
| 2Invest AG | 8,60 € | -3,80% | ||
| Medigen. | 0,0192 € | -9,43% | ||
| CO.DON . | 0,0175 € | -22,22% |
| Paion AG | 0,0615 € | -23,60% | ||
| CO.DON . | 0,0175 € | -22,22% | ||
| Medigen. | 0,0192 € | -9,43% | ||
| 2Invest AG | 8,60 € | -3,80% | ||
| Heidelbe. | 2,57 € | -1,15% | ||
| Formyco. | 19,88 € | -0,85% | ||
| Evotec SE | 4,892 € | -0,69% | ||
| BB Biote. | 41,70 ¤ | 0,00% | ||
| Qiagen NV | 31,61 € | +0,65% | ||
| Sartorius. | 190,00 € | +1,39% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| Xetra | 495,39 | -1,03% | 500,56 | 09.06.26 | |
| Aktie | Marktkap. in Mio. € | Anzahl Jahre Outperformance | Performance Ø |
|---|---|---|---|
| Sartorius AG Vz | 8.172,77 | 7 | +22,72% |
| Evotec SE | 1.731,77 | 5 | +17,33% |
| Heidelberg Pharma AG | 120,22 | 5 | +17,38% |
| Datum | Kurs |
|---|---|
| 08.06.26 | 500,56 |
| 05.06.26 | 499,92 |
| 04.06.26 | 516,28 |
| 03.06.26 | 499,69 |
| 02.06.26 | 498,85 |
| Name | Letzter | Performance | |
|---|---|---|---|
| DAX | 24.628 | +0,24% | |
| Nasdaq 100 | 29.605 | +0,62% | |
| MDAX (Perf.) | 32.135 | +0,26% | |
| SDAX (Perf.) | 18.413 | +0,41% | |
| Dow Jones Industrial. | 50.868 | +0,09% | |
| S&P 500 | 7.427 | +0,23% | |
| ATX (Austrian Traded. | 6.016 | -1,13% | |
| MSCI World | 4.766 | +0,27% | |
| Euro Stoxx 50 | 6.062 | 0,00% | |
| MDAX (Kurs) | 15.208 | -1,05% |
| Wertpapier | Beiträge | Perf. |
| Evotec SE | 5 | -3,69% |
| Heidelberg Pharma AG | 4 | - |
